S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)

Sabra Health Care REIT (SBRA) Price Target & Analyst Ratings

$13.94
-0.06 (-0.43%)
(As of 09/29/2023 ET)
Compare
Today's Range
$13.86
$14.19
50-Day Range
$11.81
$14.06
52-Week Range
$10.08
$14.32
Volume
1.74 million shs
Average Volume
2.18 million shs
Market Capitalization
$3.22 billion
P/E Ratio
N/A
Dividend Yield
8.61%
Price Target
$13.35

Sabra Health Care REIT Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 9 Analyst Ratings

Consensus Analyst Price Target

$13.35
-4.23% Downside
High Prediction$15.00
Average Prediction$13.35
Low Prediction$11.00
TypeCurrent
9/29/22 to 9/29/23
1 Month Ago
8/30/22 to 8/30/23
3 Months Ago
7/1/22 to 7/1/23
1 Year Ago
9/29/21 to 9/29/22
Consensus Rating
Hold
Hold
Reduce
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
5 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
4 Hold rating(s)
6 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
2 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$13.35$12.94$12.56$15.91
Predicted Upside-4.23% Downside8.30% Upside7.61% Upside11.97% Upside
Get Sabra Health Care REIT Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SBRA and its competitors with MarketBeat's FREE daily newsletter.


SBRA Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SBRA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Sabra Health Care REIT Stock vs. The Competition

TypeSabra Health Care REITFinance CompaniesS&P 500
Consensus Rating Score
2.11
2.40
2.49
Consensus RatingHoldHoldHold
Predicted Upside-4.23% Downside1,431.37% Upside698.21% Upside
News Sentiment RatingVery Positive News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/29/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$13.00 ➝ $15.00+7.14%
9/20/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$11.00 ➝ $15.00+12.28%
8/11/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Neutral$11.00 ➝ $14.00+12.63%
7/27/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$13.00-0.99%
7/14/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$11.00 ➝ $12.50-1.50%
5/4/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$15.00 ➝ $14.00+26.70%
4/25/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$15.00 ➝ $13.00+18.18%
4/19/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageUnderweight$11.00-2.57%
4/12/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral$13.00+10.64%
12/13/2022JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
10/10/2022Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral$13.00+3.75%
(Data available from 9/29/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












SBRA Price Target - Frequently Asked Questions

What is Sabra Health Care REIT's consensus rating and price target?

According to the issued ratings of 9 analysts in the last year, the consensus rating for Sabra Health Care REIT stock is Hold based on the current 1 sell rating, 6 hold ratings and 2 buy ratings for SBRA. The average twelve-month price prediction for Sabra Health Care REIT is $13.35 with a high price target of $15.00 and a low price target of $11.00. Learn more on SBRA's analyst rating history.

Do Wall Street analysts like Sabra Health Care REIT more than its competitors?

Analysts like Sabra Health Care REIT less than other Finance companies. The consensus rating score for Sabra Health Care REIT is 2.11 while the average consensus rating score for finance companies is 2.40. Learn more on how SBRA compares to other companies.

Is Sabra Health Care REIT being upgraded by Wall Street analysts?

Over the previous 90 days, Sabra Health Care REIT's stock had 2 upgrades by analysts.

Does Sabra Health Care REIT's stock price have much upside?

According to analysts, Sabra Health Care REIT's stock has a predicted upside of 8.64% based on their 12-month price targets.

What analysts cover Sabra Health Care REIT?

Sabra Health Care REIT has been rated by Bank of America, Berenberg Bank, Citigroup, Jefferies Financial Group, and Truist Financial in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:SBRA) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -